Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 11, 16:00
Akero Therapeutics Free Cash Flow: -250.17M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Eli Lilly & Co. | 6.436B |
| Bristol Myers Squibb Co. | 15.30B |
| Adaptive Biotechnologies Corp. | -62.94M |
| Johnson & Johnson | 20.46B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -67.17M |
| Cash from Investing (Quarterly) | 56.78M |
| Cash from Financing (Quarterly) | -34.03M |
| Free Cash Flow Per Share (Quarterly) | -0.8191 |
| Free Cash Flow to Equity (Quarterly) | -31.15M |
| Free Cash Flow to Firm (Quarterly) | -66.08M |
| Free Cash Flow Yield | -5.85% |